Patents Assigned to Neurosciences Research Foundation, Inc.
  • Patent number: 6551575
    Abstract: The present invention provides a method of identifying a compound that modulates a mammalian vestibular system. The method consists of administering a test compound to an invertebrate, and measuring a geotactic behavior of the invertebrate, where a compound that modulates the geotactic behavior of the invertebrate is characterized as a compound that modulates a mammalian vestibular system.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: April 22, 2003
    Assignee: Neurosciences Research Foundation, Inc.
    Inventor: Ralph J. Greenspan
  • Patent number: 6525090
    Abstract: Methods are disclosed for treating or preventing disorders such as mental diseases, inflammation and pain by inhibiting the enzyme anandamide amidohydrolase. A therapeutically effective level of an anandamide amidohydrolase inhibitor is administered such as a therapeutically effective level of a haloenol lactone. Preferably, the haloenol lactone is of the formula: wherein R is hydrogen, R1 is a halogen, and R2 is selected from the group consisting of aryl, aryloxy, and heteroaryl radicals, derivatives of said haloenol lactones, and mixtures thereof. The haloenol lactone, E-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyrane-2-one, is most preferred.
    Type: Grant
    Filed: April 7, 1999
    Date of Patent: February 25, 2003
    Assignee: Neurosciences Research Foundation, Inc.
    Inventors: Daniele Piomelli, Massimiliano Beltramo
  • Patent number: 6348498
    Abstract: Novel pharmaceutical therapeutic compositions and methods for using same for the treatment of pain experienced by an individual are provided. The compositions contain at least one member selected from among anandamide and palmitylethanolamide.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: February 19, 2002
    Assignee: Neurosciences Research Foundation, Inc.
    Inventors: Antonio Calignano, Giovanna La Rana, Andrea Guiffrida, Daniele Piomelli
  • Patent number: 5925672
    Abstract: Methods are disclosed for treating or preventing disorders such as mental diseases, inflammation and pain by inhibiting the enzyme anandamide amidohydrolase. A therapeutically effective level of an anandamide amidohydrolase inhibitor is administered such as a therapeutically effective level of a haloenol lactone. Preferably, the haloenol lactone is of the formula: ##STR1## wherein R is hydrogen, R.sub.1 is a halogen, and R.sub.2 is selected from the group consisting of aryl, aryloxy, and heteroaryl radicals, derivatives of said haloenol lactones, and mixtures thereof. The haloenol lactone, E-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyrane-2-one, is most preferred.
    Type: Grant
    Filed: December 6, 1996
    Date of Patent: July 20, 1999
    Assignee: Neurosciences Research Foundation, Inc.
    Inventors: Daniele Piomelli, Massimiliano Beltramo
  • Patent number: 5485546
    Abstract: An apparatus for categorizing objects employs a neural network having a plurality of cells each having memory for storing a state variable, and a plurality of synaptic junctions connecting cells of the network and having memory for storing a synaptic strength variable. A computer is used to modify the synaptic strength variable in accordance with a heterocellular synaptic modification rule. That modification rule includes both the passage of time and the values of the state variables of each cell and of those other cells having specific spatial locations with respect to the cell in three dimensional space.
    Type: Grant
    Filed: April 23, 1992
    Date of Patent: January 16, 1996
    Assignee: Neurosciences Research Foundation, Inc.
    Inventors: Allen I. Rubenstein, Joseph A. Galley, P. Read Montague, George N. Reeke
  • Patent number: 5283839
    Abstract: Apparatus which segments visual scenes into discrete objects. The apparatus is able to perceptually group the elements corresponding to a coherent figure, and to segregate them from the background or from another figure. Reentrant signaling among rhythmically active neuronal groups is used to correlate responses along spatially extended contours. The efficacy of the connections is allowed to change on a fast time scale resulting in active reentrant connections which amplify the correlations among neuronal groups and provides the desired segmentation.
    Type: Grant
    Filed: December 31, 1990
    Date of Patent: February 1, 1994
    Assignee: Neurosciences Research Foundation, Inc.
    Inventors: Gerald Edelman, Olaf Sporns, Giulio Tononi